Ocular Therapeutix Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Ocular Therapeutix, Inc. (OCUL)

9.05 -0.11 (-1.20%) USD | NASDAQ | Feb 12, 16:00

9.18 +0.13 (+1.44%) After-Hours: 18:53

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for OCUL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Boston Scientific Corp.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade
Bristol Myers Squibb Co.	Upgrade
Krystal Biotech, Inc.	Upgrade